<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2022.896393</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corneal Perforation Caused by Eyelid Margin Trichilemmal Carcinoma: A Case Report and Review of Literature</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Liying</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lin</surname> <given-names>Zhirong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1447147/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wu</surname> <given-names>Huping</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1658598/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ou</surname> <given-names>Shangkun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/311387/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Eye Institute and Affiliated Xiamen Eye Center of Xiamen University, School of Medicine, Xiamen University</institution>, <addr-line>Xiamen</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Ophthalmology, The Affiliated Hospital of Guizhou Medical University</institution>, <addr-line>Guiyang</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Fujian Key Laboratory of Ocular Surface and Corneal Diseases, Xiamen University</institution>, <addr-line>Xiamen</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jinhai Huang, Fudan University, China</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Lan Gong, Eye, Ear, Nose, and Throat Hospital of Fudan University, China; Yi Shao, Nanchang University, China</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Shangkun Ou <email>shangkun_ou&#x00040;126.com</email></corresp>
<corresp id="c002">Huping Wu <email>wuhuping123&#x00040;163.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Ophthalmology, a section of the journal Frontiers in Medicine</p></fn></author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>896393</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2022 Zhang, Lin, Wu and Ou.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Zhang, Lin, Wu and Ou</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Trichilemmal carcinoma (TLC) is a rare malignant adnexal tumor most commonly found in the elderly, usually affecting the scalp, eyelids, neck and face. Here, we first reported a rare case of corneal perforation caused by eyelid margin TLC.</p>
</sec>
<sec>
<title>Case Presentation</title>
<p>A 68-year-old female presented with 2 months history of unprovoked redness, pain and blurred vision in the left eye. On slit-lamp examination, a 1 &#x000D7; 2 mm sized aseptic corneal perforation embedded by iris prolapsed was noted. Upon detailed case investigation, we speculated that the severe meibomian gland dysfunction (MGD) and subsequent Blepharokeratoconjunctivitis (BKC) could have led to corneal perforation. The patient underwent penetrating keratoplasty to prevent ulcer enlargement and infection. However, several tiny nodules gradually developed on the eyelid margin postoperatively, accompaniedby with bleeding, burst and madarosis postoperatiely. Subsequently, biopsy revealed the growth of TLC on the eyelid margin, and lesionectomy was immediately conducted During the 1-year follow-up period, no local recurrence or metastasis was observed.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>To date, there has not been any report of corneal perforation caused by eyelid margin TLC. Consideration of the clinical presentation, feature and histopathologist will be benefit for the dignoses and treatment of TLC. Ensuring a smooth eyelid margin by total excision of TLC and consistent followup of patient will avoid recurrence.</p>
</sec></abstract>
<kwd-group>
<kwd>eyelid margin trichilemmal carcinoma</kwd>
<kwd>blepharokeratoconjunctivitis</kwd>
<kwd>corneal perforation</kwd>
<kwd>case report</kwd>
<kwd>review (article)</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<contract-sponsor id="cn002">China Postdoctoral Science Foundation<named-content content-type="fundref-id">10.13039/501100002858</named-content></contract-sponsor>
<contract-sponsor id="cn003">Major Scientific and Technological Special Project of Guizhou Province<named-content content-type="fundref-id">10.13039/501100018533</named-content></contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="18"/>
<page-count count="5"/>
<word-count count="2325"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Background</title>
<p>Trichilemmal carcinoma (TLC) is a rare malignant adnexal tumor oriented fom the external hair sheath. Usually, it develops as a large, solitary, multilobular lesion (<xref ref-type="bibr" rid="B1">1</xref>). The TLC performs a typical histopathology of trichilemmal keratinization and a peripheral palisading pattern that indicats the cells from immature pilosebaceous units. The cells are classical large, polygonal, clear cells with eccentric nuclei and atypical mitosis. Cells usually exihibit high-proliferation acticity, Ber-EP4 negative and lack hair follicle differentiation (<xref ref-type="bibr" rid="B1">1</xref>). It is a locally aggressive tumor that predominantly affects the scalp, eyelids, neck and face of the elderly (<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B6">6</xref>). The tumer can be complete excision and there is no evidence of recurrence after operation (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). There were some case reports about the eyelid disorder associated with TLC (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B9">9</xref>), while the involvement of eyelid margin by TLC and subsequent blepharokeratoconjunctivitis (BKC) have not been reported yet. Here, we report the case of corneal perforation caused by a TLC at eyelid margin.</p>
</sec>
<sec id="s2">
<title>Case Presentation</title>
<p>A 68-year-old female presented with 2 months history of redness, pain and blurred vision in the left eye. The slit-lamp examination revealed slight keratinization and multiple abnormal lashes on the left upper eyelid, clogged meibomian glands, and congestion and edema of the conjunctiva. Furthermore, diffused corneal epithelial punctate defect and neovascularization, especially a 4 &#x000D7; 3 mm sized irregular corneal epithelial defect was observed at the temporal cornea. The most crucial observation was the presence of 1 &#x000D7; 2 mm sized aseptic corneal perforation existed in the central cornea, causing iris incarceration (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The patients did not have a history of eye surgery or ocular trauma, or the immune-related disorders of rheumatoid arthritis, sj&#x000F6;gren&#x00027;s syndrome, and infectious keratitis typically associated with corneal perforation. Routine investigations were also performed to rule out mite infestation, bacterial or viral infection, allergic blepharositis and seborrheic blepharositis. Accordingly, we predicted that the rough eyelid margin resulting from severe MGD might be responsible for persistent corneal epithelial defect, neovascularization, perforation, and blepharitis. In order to prevent ulcer enlargement and intraocular infection, penetrating keratoplasty with a 7.5 mm graft size was performed immediately. During 2 months follow-up period, the graft remained clear and no serious complications occurred. However, several small nodules gradually developed on the rough eyelid margin which accompanied with bleeding, burst and madarosis (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Subsquently, to probe the reason of persistent rough eyelid we performed biopsy. Suprisingly, we observed a tumor attached to epidermis which infiltrated the hair follicle within the dermis. We diagnosed the tumor as TLC, as the sections demonstrated classical large, polygonal, clear cells with eccentric nuclei and trichilemmal keratinization (<xref ref-type="fig" rid="F2">Figure 2</xref>). TLC was immediately managed by lesionectomy. Postsurgery, the patient underwent the routine treatment for the ocular surface and was transferred to the oncology department for further general examination, which revealed no metastasis, so that chemoradiothreapy was not performed. During 1 year follow-up period, there was no evidence of local recurrence and metastasis, and the corneal graft was transparent (<xref ref-type="fig" rid="F1">Figures 1C,D</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Ocular surface findings. <bold>(A)</bold> Clinical photographs at the first visit. The left upper eyelid had slight keratinization, several aberrant lashes with clogged meibomian gland, conjunctival was congestions corneal epithelial punctate defect, perforation. <bold>(B)</bold> During the second month review after penetrating keratoplasty the patient presenting with small nodules accompanied with bleeding, burst and madarosis in the left eyelid margin. <bold>(C,D)</bold> During 1 year followup the corneal graft was transparent and the eyelid margin did not show any TLC recurrence and metastasis.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-896393-g0001.tif"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Histological section demonstrating infiltrative lobules of clear cells composed of large, polygonal, clear cells with eccentric nuclei (Haematoxylin-eosin stain; magnification &#x000D7;200).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-896393-g0002.tif"/>
</fig>
</sec>
<sec id="s3">
<title>Discussion and Conclusions</title>
<p>In 1976, Headington et al. (<xref ref-type="bibr" rid="B10">10</xref>) firstly described TLC as &#x0201C;a histologically invasive, cytologically atypical, clear cell neoplasm of adnexal keratinocytes which is in continuity with the epidermis and/or follicular epithelium&#x0201D;. It is commonly seen on the sun-exposed skin of the elderly (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>), especially affecting the age group of 40-year-old or older (<xref ref-type="bibr" rid="B13">13</xref>), without gender pre-dilection (<xref ref-type="bibr" rid="B11">11</xref>). Dailey et al. (<xref ref-type="bibr" rid="B9">9</xref>) was the first to report TLC growth in the eyelid margin, however, the involvement of the eyelid margin and the subsequent corneal perforation is rarely reported and the pathogenesis of TLC is not known clearly. Previous studies have postulated that the actinic damage (<xref ref-type="bibr" rid="B14">14</xref>), transformation from benign trichilemmoma (<xref ref-type="bibr" rid="B7">7</xref>) or long term low dose irradiation (<xref ref-type="bibr" rid="B15">15</xref>) could be the etiology of TLC. Histologically, TLC is charecterised by single, exophytic nodular appearance, measuring less than 2 cm in diameter, and sometimes it complicates with ulcers and keratosis (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Microscopically, TLC usually demonstrates proliferative lobules centrered on pilosebaceous, composed of polygonal clear cells with high-grade mitotic potential (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). But in our case we noted several diffused nodules, ulcerations on the upper eyelid margin, and was poorly circumscribed. There was no change in the palpebral conjunctiva.</p>
<p>TLC are often confused with other skin cancer, such as clear cell basal cell carcinoma (BCC) with few keratin cysts and peripheral palisading cells within the basaloid islands, squamous cell carcinoma (SCC) with clear cell differentiation of flat cells, trichoepithelioma which are composed of variety of concentrically laminated keratin riched horn cysts, keratoacanthoma which was similar as SCC while it was benign and could resolve spontaneously (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B16">16</xref>) yet can be differentially diagnosed based on their growth pattern and histopathology.</p>
<p>TLC has a benign clinical course, and there is no evidence of recurrence after complete excision (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Billingsley et al. (<xref ref-type="bibr" rid="B11">11</xref>) and Lai et al. (<xref ref-type="bibr" rid="B8">8</xref>) recommended Mohs micrographic surgery as the treatment to ensure complete surgical excision. Besides, full dose irradiation can also be applied to treat TLC and it is very important to offer careful follow-up to the patients.</p>
<p>In the early stage of our case, the clinical manifestations of TLC was not apparent. Our diagnosis was misleaded as BKC because of the eyelid margin only showed slight keratinization and roughness devoed of ulcers or bleeding. Conjunctival and corneal involvement was considered to be the sequel of BKC, and it affected both the meibomian gland and the ocular surface, leading to keratitis, corneal thinning or perforation, vascularization and scarring. BKC is a chronic inflammatory disorder induced by infections, immunologic conditions, dermatoses, toxic conditions, trauma and tumors (<xref ref-type="bibr" rid="B17">17</xref>). Rectifying the eyelid margin should be considered crucial in the treatment of BKC as they may mediate a chronic inflammatory reponse. The application of ointments and corticosteroids is effective to manage the BKC. However, the BKC caused by tumer or immunemediated diseases do not respond to therapy, particularly if it is resulted in conjunctival cicatricial changes or loss of eyelashes (<xref ref-type="bibr" rid="B18">18</xref>).</p>
<p>In our case, we excluded common causes of blepharositis, and did not comprehend that it was a rare tumor until the ulcer lesions appeared. Whats more, the penetrating keratoplasty and tumer complete excision were timely and effective.</p>
</sec>
<sec sec-type="data-availability" id="s4">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s5">
<title>Ethics Statement</title>
<p>This case report was approved by the Ethics Committee of Xiamen University affiliated Xiamen Eye Center and written informed consent was obtained from the patient. The patient consented to publish the image of her eye and other results of her medical examination in this manuscript or paper which may be published in this journal.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>LZ designed this study, performed the literature search, and wrote the manuscript. ZL, HW, and SO designed this study. All authors have read and approved the manuscript.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>This study was supported by the National Natural Science Foundation of China [Grant Numbers: 82101084 and 82060173], China Postdoctoral Science Foundation [Grant Number: 2021M69898], the Xiamen Science and Technology Program for Public Wellbeing [Grant Number: 3502Z20209183], and Science and Technology Support Program of Guizhou Province [20204Y145]. The funders had no role in the study design, data collection and analysis, publishing decision, or preparation of the manuscript.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x00027;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname> <given-names>JH</given-names></name> <name><surname>Lee</surname> <given-names>C</given-names></name> <name><surname>Lee</surname> <given-names>KS</given-names></name> <name><surname>Pak</surname> <given-names>CS</given-names></name> <name><surname>Sun</surname> <given-names>CH</given-names></name> <name><surname>Koh</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>The molecular pathogenesis of Trichilemmal carcinoma</article-title>. <source>BMC Cancer.</source> (<year>2020</year>) <volume>20</volume>:<fpage>516</fpage>. <pub-id pub-id-type="doi">10.1186/s12885-020-07009-7</pub-id><pub-id pub-id-type="pmid">32493317</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Usseglio</surname> <given-names>J</given-names></name> <name><surname>Pag&#x000E8;s</surname> <given-names>E</given-names></name> <name><surname>Guyot</surname> <given-names>A</given-names></name> <name><surname>Laloze</surname> <given-names>J</given-names></name> <name><surname>Ferri</surname> <given-names>J</given-names></name></person-group>. <article-title>Trichilemmal carcinoma of the scalp</article-title>. <source>Int J Oral Maxillofac Surg.</source> (<year>2021</year>) <volume>50</volume>:<fpage>1289</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijom.2021.02.008</pub-id><pub-id pub-id-type="pmid">33642152</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arslan</surname> <given-names>Z</given-names></name> <name><surname>Bali</surname> <given-names>ZU</given-names></name> <name><surname>Evrenos</surname> <given-names>MK</given-names></name> <name><surname>Temiz</surname> <given-names>P</given-names></name> <name><surname>Ermertcan</surname> <given-names>AT</given-names></name></person-group>. <article-title>Dermoscopic features of trichilemmal carcinoma</article-title>. <source>Indian J Dermatol Venereol Leprol.</source> (<year>2019</year>) <volume>85</volume>:<fpage>321</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.4103/ijdvl.IJDVL_468_18</pub-id><pub-id pub-id-type="pmid">30860170</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamman</surname> <given-names>MS</given-names></name> <name><surname>Brian Jiang</surname> <given-names>SI</given-names></name></person-group>. <article-title>Management of trichilemmal carcinoma: an update and comprehensive review of the literature</article-title>. <source>Dermatol Surg.</source> (<year>2014</year>) <volume>40</volume>:<fpage>711</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/dsu.0000000000000002</pub-id><pub-id pub-id-type="pmid">25111341</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname> <given-names>MK</given-names></name> <name><surname>Tenzel</surname> <given-names>P</given-names></name> <name><surname>Iacob</surname> <given-names>C</given-names></name> <name><surname>Jordan</surname> <given-names>A</given-names></name> <name><surname>Reddy</surname> <given-names>HS</given-names></name></person-group>. <article-title>Eyelid trichilemmal carcinoma</article-title>. <source>Saudi J Ophthalmol.</source> (<year>2017</year>) <volume>31</volume>:<fpage>183</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.sjopt.2017.05.002</pub-id><pub-id pub-id-type="pmid">28860920</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waqas</surname> <given-names>O</given-names></name> <name><surname>Faisal</surname> <given-names>M</given-names></name> <name><surname>Haider</surname> <given-names>I</given-names></name> <name><surname>Amjad</surname> <given-names>A</given-names></name> <name><surname>Jamshed</surname> <given-names>A</given-names></name> <name><surname>Hussain</surname> <given-names>R</given-names></name></person-group>. <article-title>Retrospective study of rare cutaneous malignant adnexal tumors of the head and neck in a tertiary care cancer hospital: a case series</article-title>. <source>J Med Case Rep.</source> (<year>2017</year>) <volume>11</volume>:<fpage>67</fpage>. <pub-id pub-id-type="doi">10.1186/s13256-017-1212-8</pub-id><pub-id pub-id-type="pmid">28284233</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname> <given-names>JP</given-names></name> <name><surname>Tellechea</surname> <given-names>O</given-names></name> <name><surname>Cunha</surname> <given-names>MF</given-names></name> <name><surname>Baptista</surname> <given-names>AP</given-names></name></person-group>. <article-title>Trichilemmal carcinoma: review of 8 cases</article-title>. <source>J Cutan Pathol.</source> (<year>1993</year>) <volume>20</volume>:<fpage>44</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0560.1993.tb01248.x</pub-id><pub-id pub-id-type="pmid">8468416</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname> <given-names>TF</given-names></name> <name><surname>Huilgol</surname> <given-names>SC</given-names></name> <name><surname>James</surname> <given-names>CL</given-names></name> <name><surname>Selva</surname> <given-names>D</given-names></name></person-group>. <article-title>Trichilemmal carcinoma of the upper eyelid</article-title>. <source>Acta Ophthalmol Scand.</source> (<year>2003</year>) <volume>81</volume>:<fpage>536</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1034/j.1600-0420.2003.00132.x</pub-id><pub-id pub-id-type="pmid">14510806</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dailey</surname> <given-names>JR</given-names></name> <name><surname>Helm</surname> <given-names>KF</given-names></name> <name><surname>Goldberg</surname> <given-names>SH</given-names></name></person-group>. <article-title>Tricholemmal carcinoma of the eyelid</article-title>. <source>Am J Ophthalmol.</source> (<year>1993</year>) <volume>115</volume>:<fpage>118</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9394(14)73540-8</pub-id><pub-id pub-id-type="pmid">8420367</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Headington</surname> <given-names>JT</given-names></name></person-group>. <article-title>Tumors of the hair follicle. a review</article-title>. <source>Am J Pathol.</source> (<year>1976</year>) <volume>85</volume>:<fpage>479</fpage>&#x02013;<lpage>514</lpage>.</citation>
</ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Billingsley</surname> <given-names>EM</given-names></name> <name><surname>Davidowski</surname> <given-names>TA</given-names></name> <name><surname>Maloney</surname> <given-names>ME</given-names></name></person-group>. <article-title>Trichilemmal carcinoma</article-title>. <source>J Am Acad Dermatol.</source> (<year>1997</year>) <volume>36</volume>:<fpage>107</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0190-9622(97)70339-6</pub-id><pub-id pub-id-type="pmid">8996274</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>MG</given-names></name> <name><surname>Min</surname> <given-names>HG</given-names></name> <name><surname>Jung</surname> <given-names>SY</given-names></name> <name><surname>Yang</surname> <given-names>JM</given-names></name> <name><surname>Lee</surname> <given-names>ES</given-names></name></person-group>. <article-title>Trichilemmal carcinoma with a cutaneous horn</article-title>. <source>Br J Dermatol.</source> (<year>2000</year>) <volume>143</volume>:<fpage>646</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2133.2000.03728.x</pub-id><pub-id pub-id-type="pmid">10971347</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname> <given-names>PE</given-names></name> <name><surname>Marrogi</surname> <given-names>AJ</given-names></name> <name><surname>Williams</surname> <given-names>DJ</given-names></name> <name><surname>Cherwitz</surname> <given-names>DL</given-names></name> <name><surname>Wick</surname> <given-names>MR</given-names></name></person-group>. <article-title>Tricholemmal carcinoma: clinicopathologic study of 10 cases</article-title>. <source>J Cutan Pathol.</source> (<year>1992</year>) <volume>19</volume>:<fpage>100</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0560.1992.tb01350.x</pub-id><pub-id pub-id-type="pmid">1597565</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misago</surname> <given-names>N</given-names></name> <name><surname>Tanaka</surname> <given-names>T</given-names></name> <name><surname>Kohda</surname> <given-names>H</given-names></name></person-group>. <article-title>Trichilemmal carcinoma occurring in a lesion of solar keratosis</article-title>. <source>J Dermatol.</source> (<year>1993</year>) <volume>20</volume>:<fpage>358</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1111/j.1346-8138.1993.tb01298.x</pub-id><pub-id pub-id-type="pmid">8349925</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname> <given-names>KO</given-names></name> <name><surname>Lim</surname> <given-names>IJ</given-names></name> <name><surname>Baladas</surname> <given-names>HG</given-names></name> <name><surname>Tan</surname> <given-names>WT</given-names></name></person-group>. <article-title>Multiple tumour presentation of trichilemmal carcinoma</article-title>. <source>Br J Plast Surg.</source> (<year>1999</year>) <volume>52</volume>:<fpage>665</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1054/bjps.1999.3180</pub-id><pub-id pub-id-type="pmid">10658141</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>JH</given-names></name> <name><surname>Shin</surname> <given-names>YW</given-names></name> <name><surname>Oh</surname> <given-names>YH</given-names></name> <name><surname>Lee</surname> <given-names>YJ</given-names></name></person-group>. <article-title>Trichilemmal carcinoma of the upper eyelid: a case report</article-title>. <source>Korean J Ophthalmol.</source> (<year>2009</year>) <volume>23</volume>:<fpage>301</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.3341/kjo.2009.23.4.301</pub-id><pub-id pub-id-type="pmid">20046693</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hammersmith</surname> <given-names>KM</given-names></name></person-group>. <article-title>Blepharokeratoconjunctivitis in children</article-title>. <source>Curr Opin Ophthalmol.</source> (<year>2015</year>) <volume>26</volume>:<fpage>301</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/ICU.0000000000000167</pub-id><pub-id pub-id-type="pmid">26058029</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amescua</surname> <given-names>G</given-names></name> <name><surname>Akpek</surname> <given-names>EK</given-names></name> <name><surname>Farid</surname> <given-names>M</given-names></name> <name><surname>Garcia-Ferrer</surname> <given-names>FJ</given-names></name> <name><surname>Lin</surname> <given-names>A</given-names></name> <name><surname>Rhee</surname> <given-names>MK</given-names></name> <etal/></person-group>. <article-title>Blepharitis preferred practice pattern&#x000AE;</article-title>. <source>Ophthalmology.</source> (<year>2019</year>) <volume>126</volume>:<fpage>P56</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.ophtha.2018.10.019</pub-id><pub-id pub-id-type="pmid">30366800</pub-id></citation></ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>BKC</term>
<def><p>Blepharokeratoconjunctivitis</p></def></def-item>
<def-item><term>TLC</term>
<def><p>Trichilemmal carcinoma</p></def></def-item>
<def-item><term>BCC</term>
<def><p>Basal cell carcinoma</p></def></def-item>
<def-item><term>SCC</term>
<def><p>Squamous cell carcinoma</p></def></def-item>
<def-item><term>PTT</term>
<def><p>Proliferating trichilemmal tumors.</p></def></def-item>
</def-list>
</glossary> 
</back>
</article>